Lifastuzumab Antibody
Lifastuzumab is a humanized monoclonal antibody targeting the sodium-dependent phosphate transporter NaPi2b. It is conjugated to the microtubule inhibitor monomethyl auristatin E (MMAE), enabling targeted cytotoxicity. This antibody-drug conjugate is utilized in preclinical oncology research to investigate targeted therapies, particularly in ovarian and non-small cell lung cancer models.
Product Specifications
Product Name Alternative
NaPi2b, Sodiumdependent phosphate transporter, Sodiumdependentphosphatetransporter
Target
Sodium-dependent phosphate transporter
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Pharmacology & Drug Discovery
Concentration
5.49 mg/mL
Purity
97.00% (May vary between batches)
Molecular Weight
145.5 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Paf1 (NM_001024898) Rat Tagged ORF Clone Lentiviral Particle
